[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tandem Diabetes Care (TNDM)

Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 878,542
  • Shares Outstanding, K 68,529
  • Annual Sales, $ 1,015 M
  • Annual Income, $ -204,710 K
  • EBIT $ -84 M
  • EBITDA $ -68 M
  • 60-Month Beta 1.64
  • Price/Sales 0.96
  • Price/Cash Flow N/A
  • Price/Book 7.32

Options Overview Details

View History
  • Implied Volatility 73.58% (+10.07%)
  • Historical Volatility 80.56%
  • IV Percentile 48%
  • IV Rank 30.08%
  • IV High 125.46% on 09/11/25
  • IV Low 51.27% on 06/12/25
  • Expected Move (DTE 32) 1.92 (14.98%)
  • Put/Call Vol Ratio 0.98
  • Today's Volume 3,468
  • Volume Avg (30-Day) 1,367
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 29,487
  • Open Int (30-Day) 15,770
  • Expected Range 10.90 to 14.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.30
  • Number of Estimates 6
  • High Estimate $-0.17
  • Low Estimate $-0.41
  • Prior Year $-0.48
  • Growth Rate Est. (year over year) +37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.26 +4.57%
on 05/15/26
21.86 -41.35%
on 04/20/26
-7.84 (-37.95%)
since 04/15/26
3-Month
12.26 +4.57%
on 05/15/26
29.65 -56.76%
on 02/24/26
-6.13 (-32.35%)
since 02/13/26
52-Week
9.98 +28.46%
on 08/07/25
29.65 -56.76%
on 02/24/26
-9.88 (-43.52%)
since 05/15/25

Most Recent Stories

More News
Tandem Diabetes’s Q1 Earnings Call: Our Top 5 Analyst Questions

Tandem Diabetes’s Q1 Earnings Call: Our Top 5 Analyst Questions

TNDM : 12.82 (-9.40%)
3 Healthcare Stocks We’re Skeptical Of

3 Healthcare Stocks We’re Skeptical Of

UHS : 168.64 (-1.19%)
TNDM : 12.82 (-9.40%)
BIIB : 192.95 (+0.83%)
Tandem Diabetes Care Q1 Earnings Call Highlights

Tandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward pharmacy-channel...

TNDM : 12.82 (-9.40%)
Why Tandem Diabetes (TNDM) Shares Are Trading Lower Today

Why Tandem Diabetes (TNDM) Shares Are Trading Lower Today

TNDM : 12.82 (-9.40%)
TNDM Q1 Deep Dive: Margin Expansion and Pipeline Advances Amid Business Model Shift

TNDM Q1 Deep Dive: Margin Expansion and Pipeline Advances Amid Business Model Shift

TNDM : 12.82 (-9.40%)
Tandem Diabetes’s (NASDAQ:TNDM) Q1 CY2026: Beats On Revenue, Stock Jumps 10.9%

Tandem Diabetes’s (NASDAQ:TNDM) Q1 CY2026: Beats On Revenue, Stock Jumps 10.9%

TNDM : 12.82 (-9.40%)
Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2026 and reaffirmed financial...

TNDM : 12.82 (-9.40%)
Tandem Diabetes Care Reports Tomorrow With Its Pharmacy Bet Still Largely Unproven

Barchart Research What to Expect from TNDM Earnings TNDM Generated May 6, 2026 Current Price $18.03 EPS Estimate $$-0.46 Consensus Rating Moderate Buy Average Move 21.47% Tandem Diabetes Care Reports Tomorrow...

TNDM : 12.82 (-9.40%)
Tandem Diabetes (TNDM) Q1 Earnings: What To Expect

Tandem Diabetes (TNDM) Q1 Earnings: What To Expect

TNDM : 12.82 (-9.40%)
3 Russell 2000 Stocks We Approach with Caution

3 Russell 2000 Stocks We Approach with Caution

AOUT : 8.71 (-5.12%)
TNDM : 12.82 (-9.40%)
MNRO : 15.76 (-3.43%)

Business Summary

Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin...

See More

Key Turning Points

3rd Resistance Point 15.00
2nd Resistance Point 14.34
1st Resistance Point 13.58
Last Price 12.82
1st Support Level 12.16
2nd Support Level 11.50
3rd Support Level 10.74

See More

52-Week High 29.65
Fibonacci 61.8% 22.14
Fibonacci 50% 19.81
Fibonacci 38.2% 17.49
Last Price 12.82
52-Week Low 9.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.